| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02435836 Details | 2015-09-21 Interventional | 3 | 631 | Aripiprazole Schizophrenia | Study terminated when aripiprazole available commercially per protocol The study was terminated prematurely by the sponsor. The protocol specified that the study would run until Abilify (aripiprazole) was commercially available in all site countries. | |||
| NCT02480010 Details | 2015-09-18 Interventional | 2 | 68 | Pertuzumab Prostatic Neopl… Prostate Cancer | The study was terminated at the time of interim analysis since none of the participants showed
a PSA response. The study was terminated at the time of interim analysis since none of the participants showed a PSA response. | |||
| NCT02053597 2013-000173-77 Details | 2015-09-17 Interventional | 2 | 0 | Doxorubicin Paclitaxel Breast Neoplasm… Breast Cancer | due to evolving scientific knowledge in the field that would make the questions being addressed
in the trial less relevant - | |||
| NCT02338050 Details | 2015-09-16 Interventional | 2 | 1 | Immunotoxin HA2… Leukemia Leukemia, Lymph… Neoplasm, Resid… Precursor Cell … Acute Lymphobla… | - - | |||
| NCT02408419 Details | 2015-09-14 Interventional | 4 | 0 | Bupivacaine Fractures, Bone Hip Fractures | The study was completely redesigned - | |||
| NCT02248870 Details | 2015-09-14 Interventional | 4 | 7 | Dexamethasone Fractures, Bone Hip Fractures Hip Fracture | Less inclusions than expected with the given criteria - | |||
| NCT01112878 Details | 2015-09-14 Interventional | 4 | 0 | Clonidine Gabapentin Knee Arthroscop… Shoulder Arthro… | Several studies going on at the same time. - | |||
| NCT00782951 2006-002571-40 Details | 2015-09-14 Interventional | 2 | 11 | Morphine Tooth, Impacted Analgesia | - - | |||
| NCT00953706 2009-010261-23 Details | 2015-09-11 Interventional | 2 | 140 | Ivacaftor Cystic Fibrosis Fibrosis | Following review of results obtained from a pre-specified 6-month analysis of Part B data the
study was terminated on the basis of futility. In Part B, the treatment duration was 96 weeks; however, due to early study termination all analysis were performed up to Week 64, as planned. | |||
| NCT00479466 Details | 2015-09-09 Interventional | 2 | 342 | Metformin Diabetes Mellit… Diabetes Mellit… | Sufficient data regarding the dose-response to MK-0893 had been obtained from the first cohort
of the study to assess the safety and efficacy Sufficient data regarding the dose-response to MK-0893 had been obtained from the first cohort of the study to assess the safety and efficacy, thus the study was discontinued. | |||
| NCT02090348 2013-001025-53 Details | 2015-09-07 Interventional | 4 | 0 | Dimethyl Fumara… Multiple Sclero… Multiple Sclero… Sclerosis Relapsing-Remit… | The study was withdrawn for business reasons. The decision to stop the TECNERGY study was not a
result of any safety or efficacy concerns. - | |||
| NCT01179100 Details | 2015-09-07 Interventional | 4 | 0 | Lidocaine Elderly General Anesthe… Surgeries Requi… | Patient population require high amount of opioids. - | |||
| NCT01057212 Details | 2015-09-07 Interventional | 2 | 6 | Bevacizumab Carcinoma, Non-… Lung Neoplasms Non-squamous No… | Lack of support from pharmaceutical collaborator. - | |||
| NCT00460317 Details | 2015-09-07 Interventional | 3 | 1450 | Carboplatin Motesanib dipho… Paclitaxel Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | Amgen discontinued the development of AMG706 because 20050201 did not meet its primary
objective. - | |||
| NCT00395057 Details | 2015-09-07 Interventional | 2 | 138 | Ranibizumab Choroidal Neova… Macular Degener… Neovascularizat… Age-Related Mac… Choroid Neovasc… | The study was terminated early due to company decision (non-safety related). The study was terminated early due to a company decision (non-safety related). Because the study was terminated early, data for certain outcome measures (ie, "Visual Functioning Questionnaire [VFQ] at Month 3") were not analyzed. | |||
| NCT02331563 Details | 2015-09-04 Interventional | 3 | 0 | Bupivacaine Dexmedetomidine Postoperative N… Vomiting | patients should have assurance to attend this study, money is the main problem - | |||
| NCT01238133 Details | 2015-09-04 Interventional | 1 | 14 | 2,2-dimethyl-N-… Albumin-Bound P… Carboplatin Gamma Secretase… Paclitaxel Breast Neoplasm… Triple Negative… Estrogen Recept… HER2/Neu Negati… Progesterone Re… Stage IIA Breas… Stage IIB Breas… Stage IIIA Brea… Stage IIIB Brea… Stage IIIC Brea… Triple-Negative… | - - | |||
| NCT01184287 Details | 2015-09-02 Interventional | 2 | 0 | Ranpirnase Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | Program discontinued - | |||
| NCT00423163 Details | 2015-09-02 Interventional | 4 | 0 | Micafungin Voriconazole Aspergillosis Aspergillosis/B… Aspergillosis/I… | An alternative joint industry effort will provide information on combination versus single
agent therapy for treatment of aspergillosis - | |||
| NCT00331045 Details | 2015-09-02 Interventional | 2 | 21 | Alvimopan Constipation Cancer | Subject registration did not proceed as expected; difficult to complete within scheduled time
frame; prematurely terminated w/ 21 subjects randomized. - |